Recent Finacing
Recent Raise
Alesta Therapeutics is a Leiden-based biotech developing orally active small-molecule therapies for rare diseases, advancing ALE1 (oral PPi-reducing candidate for hypophosphatasia) and ALE2 (GCN2 inhibitor for CMT).
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
